Antiviral Drug Discovery and Development


The Antiviral Drug Discovery and evolution Center (AD3C), organize out of the University of Alabama at Birmingham (UAB) has, at its core, the report to bloom new minuscule particle cures for appearing and re-appearing viral microbes. The fortunate development of antiviral drugs is highly hanging on a close interchange and cooperation linking the chemist and the biologist. This is decorate by a number of typical examples: S-adenosylhomocysteine (SAH) hydrolase restrain which show wide-spectrum antiviral pursuit, bromovinyldeoxyuridine (BVDU) and that are highly mostly inhibitors of varicella-zoster virus (VZV), (dideoxy)nucleoside back transcriptase inhibitors (NRTIs) and non-nucleoside reverse transcriptase inhibitors (NNRTIs)



 


    Related Conference of Antiviral Drug Discovery and Development

    November 25-26, 2025

    21st World Summit on Blockchain Technology

    Amsterdam, Netherlands
    February 04-05, 2026

    18th International Conference on Gynecology

    Rome, Italy
    February 25-26, 2026

    15th International Conference on Herbal Medicine and Acupuncture

    Aix-en-Provence, France
    March 09-10, 2026

    13th World Machine Learning and Deep learning Conference

    Singapore City, Singapore
    March 26-27, 2026

    12th World Congress on Anesthesia and Critical Care

    Amsterdam, Netherlands
    April 20-21, 2026

    47th International Summit on Human Anatomy & Physiology

    Barcelona, Spain
    October 19-20, 2026

    12th World Congress on Medicinal Plants and Marine Drugs

    Aix-en-Provence, France

    Antiviral Drug Discovery and Development Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in